This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. plays a critical role in pulmonary hypertension (PH)-associated vascular remodeling. However, the signaling mechanisms remain unclear. The purpose of this study was to investigate the role of 15-lipoxygenase-2 (15-LO-2)/15-HETE-mitogen-activated protein kinases (MAPKs) pathway in hypoxia-induced pulmonary vascular remodeling and the underlying mechanisms. Methods: The arterial wall thickness was measured by hematoxylin and eosin (HE) staining in distal pulmonary arteries isolated from normal and PAH patient-derived lungs. The protein expression of phosphorylated extracellular signal-regulated kinase (p-ERK) and phosphorylated p38 mitogen-activated protein kinases (p-p38MAPK) were measured by Western blot in the lungs of PAH patients and hypoxia-induced rats. The apoptosis of cultured rat pulmonary arterial smooth muscle cells (PASMCs) was determined by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and Flow cytometry. The cell proliferation and cell cycle in PASMCs following hypoxia were analyzed by bromodeoxyuridine Results: Our results showed that the levels of p-ERK and p-p38MAPK were both drastically elevated in lungs from human patients and hypoxic rats. The HE staining revealed that the medial wall thickness was higher in patients with PAH than normal humans. In cultured PASMCs, Hypoxia stimulated the cell proliferation, the cell cycle progression, and subsequently promoted cell differentiation and cell migration leading to the suppressed cell apoptosis. Furthermore, MAPKs-induced cell proliferation and anti-apoptosis in PASMCs is15-LO-2/15HETE activation-dependent. Conclusion: Our study indicates that hypoxia-induced pulmonary vascular remodeling is associated with increased
Introduction
Pulmonary hypertension (PH) is a refractory disease characterized by increased pulmonary vascular resistance (PVR), leading to increased right ventricular afterload, eventually progression to right heart failure and death [1] [2] [3] [4] . Vasoconstriction, structural remodeling and thrombosis in situ have been shown as the main pathological characteristics in the development of PH [2] . Numerous evidences indicate that hypoxia, a well-known stimulus of PH, induces pulmonary vascular remodeling via stimulating cell proliferation, particularly in the tunica media of smooth muscle cells [4] [5] [6] .
The enhanced proliferation and suppressed normal apoptosis of vascular smooth muscle cells (VSMCs) are considering as the major reasons of medial hypertrophy, vascular remodeling [7] . Furthermore, VSMCs can undergo reversible phenotypical changes in response to chronic hypoxia, and retain the capacities of proliferation and migration as well as secretion of matrix proteins [8] . The above evidence suggests that, the unbalance between proliferation and apoptosis in VSMCs may contribute to structure-functional alterations of the pulmonary arteries and the development of PH.
Mitogen-activated protein kinase (MAPK) is a key enzyme that promotes cellular growth and proliferation through the phosphorylation and inactivation of pro-apoptotic proteins.
including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinases (p38MAPK) [9] . MAPKs can be activated by a variety of stimuli, such as mitogens, growth factors, hormones, oxidants and stress factors etc [10, 11] . In the MAPKs superfamily, increased activation of ERK is a key step in cell proliferation in response to growth factors, agonists, and hormones [12] [13] [14] . In contrast, p38MAPK has been found to be involved in apoptosis, endotoxic response, and osmotic stress [15] [16] [17] [18] . JNK/stress activated protein kinase (SAPK) is response to growth factors, cytokines, environmental stress, ultraviolet light, oxidative stress, and heat shock [19] [20] [21] [22] [23] . It has been shown that activation of JNK by 5-hydroxytryptamine results in the enhanced proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) [24] . Recent studies apoptosis as well as differentiation of s mesenchymal stem cells [25] [26] [27] . The evidence suggests that MAPKs contribute to the hypoxia-induced PAH-associated pulmonary vascular remodeling.
15-Hydroxyeicosatetr-aenoic acid (15-HETE), a metabolite of arachidonic acid catalyzed [28] . We have previously shown that 15-HETE mediated hypoxia-induced pulmonary of intimal endothelial cells [7, 25, 29, 30] . However, the mechanisms in molecular level underlying the hypoxia-induced pulmonary vascular remodeling are not fully understood.
In this study, we sought to determine whether 15-LO-2/15-HETE mediated hypoxiainduced pulmonary vascular remodeling through stimulates MAPK pathway.
Patients Selection
Written informed consent was obtained from all subjects. The treatment evaluated for this study was approved by the Harbin Medical University Ethical Committee for Use of Human Samples between October rest. We excluded patients with (1) patients with congenital heart diseases and (2) patients with unstable condition. Finally, twenty patients were recruited, and all of them underwent RHC. Human lung specimens were obtained from lung transplantation (PAH) or from lobectomy or pneumonectomy for localized lung cancer (Control). The selected patients were all underwent pulmonary remodeling, samples from Group 3 are patients with pulmonary hypertension due to lung diseases and /or hypoxaemia, six were with chronic obstructive pulmonary disease (COPD), four were with interstitial lung disease and two were with alveolar hypoventilation disorders. None of the patients harbor germline mutations BMPR2, ALK1 or ENG PAH (Table 1) . Fresh lung tissues was immediately placed in cold oxygenated Krebs solution (116 mM NaCl, 4.2 7.4). One of the fresh lung tissues was used for immunocytochemistry, and the rest of fresh lung tissues were used for pulmonary artery dissection. The distal pulmonary arteries were micro-dissected to achieve free of surrounding tissue under microscope. In the human samples the diameter range of pulmonary arterioles
Clinical and Hemodynamic Evaluation
Hemodynamic parameters including mean right atrial pressure (mRAP), mPAP and PCWP were value of measurements at three time points 
Animals and lung tissues preparation
Adult male rats were randomized to 9 days of normal and hypoxic environments with fractional inspired oxygen (FiO 2 ) 0.21 and 0.12, respectively, as previously described [28] . Normoxic rats were kept in the same room adjacent to the hypoxic chamber. To test the effects of nordihydroguaiaretic acid (NDGA), U0126, SB203580 and Sp600125 on hypoxia, rats were given NDGA (650 mg/kg body weight (b.w.), orally, once daily) [7] , U0126 (15 mg/kg b.w., orally, once daily), SB203580 (15 mg/kg b.w. orally, once daily), Sp600125 (10 mg/kg b.w., orally, oncedaily) since 2 days before hypoxia until they were used for experiment (9 days after hypoxia). At the end of the 9 days exposure period, right ventricular systolic pressure (RVSP) was measured by right heart catheterization, according to Song Y [31] . Then the heart and lungs were removed after euthanized. The lung tissues were used for a morphology section and the harvest of pulmonary arteries.
The Hemodynamic Evaluation of hypoxia -model A 1.2 French Pressure Catheter (Scisense Inc.) was connected to the Scisense FA-404 recorder. When the right jugular vein was exposed, the catheter was inserted into the vein, then advanced into superior vena RVSP the thorax was opened and the heart was dissected and weighed for calculation of the right ventricular hypertrophy index (ratio of right ventricular free wall weight over sum of septum plus left ventricular free wall weight: (RV/LV+S).
Cell culture
The primary culture of rat pulmonary artery smooth muscle cells (PASMCs) was prepared according to contained 20%-fetal bovine serum, 1% penicillin and streptomycin. Passages 2-3 were used for the further experiments. Before experiment, the PASMCs were starvation for 24 h in the DMEM medium without serum. Then treated with siRNA plus 15-HETE (1μmol/L) [29] in 5% FBS-DMEM, or were exposed to hypoxia (92% N 2 -5%CO 2 -3% O 2 ) in the absence or presence of U0126 (5μmol/L), SB203580 (5μmol/L).
Morphometric Analysis
The lung tissues were sliced into tissue blocks, and immersed in 4% paraformaldehyde for overnight 
siRNA Design and Transfections
To silence the expression of 15-LO-2 gene, PASMCs were transfected with small interfering RNA, which was designed and synthesized by Bioneer. Non-targeted control siRNA (siNC) was used as negative control. The sense sequence of siRNA against 15-LO-2 and non-targeted control sequence were listed below: then 2 μg siRNA and 10 μl X-tremeGene siRNA Transfection Reagent were respectively diluted in serum-free Opti-MEM-1 medium for 5 min, then mixed together (siRNA/Transfection Reagent) at room temperature for another 20 min before added onto cells. After transfections, cells were quiesced for 24 h and used as required.
MTT assay
Cell viability was determined by the 3-(4, 5dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay as described previously [29] . PASMCs were cultured in 96-well culture clusters (about 1×10 4 cells per well), and then the cells were treated with U0126 (5μmol/L), SB203580 (5μmol/L), 15-HETE (1μmol/L), 15-HETE Plus U0126, 15-HETE Plus SB203580, ethanol (vehicle) in DMEM with 5% FBS, respectively. Then the samples were exposed to hypoxia (3% O 2 ). Ethanol and other agents at the indicated concentrations were added every 24 h. After incubation in 37 for 24 h, the cells were treated with 0.5% MTT for another 4 h. Amount of blue formazan dye formed from MTT is proportional to the number of survival cells. The reaction was terminated by adding DMSO (dimethyl sulfoxide) to the medium. The spectrophotometer absorbance at 540 nm was measured.
Bromodeoxyuridine incorporation
PASMCs were plated at 1×10 4 cells/well in 96-well plates, and then subjected to growth arrest for 24 h before exposed to hypoxia or treated with different agents in 5% FBS DMEM. BrdU incorporation was dried and incubated 1 h at room temperature with mouse anti-BrdU monoclonal antibody (diluted 1:200). The antibody was aspirated. The cells were washed 3 times and then incubated with peroxidase-conjugate goat anti-mouse IgG (1:2000) at room temperature for 30 min. The cells were washed 3 times, and 100 μl substrates were added to each well and incubated for 30 min in darkness. Finally, positive stains were determined at the absorbance at dual-wave lengths of 450 and 540 nm.
Cell cycle and DNA analysis
by hypoxia or MAPK. We analyzed the proportion of cells in G 0 /G 1 , S and G 2 reported recently [29] . After exposure to drugs or hypoxia, the cells were treated by trypsin, then centrifuged and suspended with 1ml of cold PBS. Following twice washes with PBS, the cells were resuspended and 4 events were accumulated in a histogram. The proportions of cells in the different phases of the cell cycle were calculated from each histogram.
mmuno luorescence study and microscopic o servation
PASMCs were cultured on a poly-L-lysine-coated cover glass (15 mm diameter) and washed three permeabilization with 0.01% Triton X-100 for 10 min, the cells were blocked with 3% normal bovine serum 1:500, 1:200)in PBS at 4 °C overnight. After three washes with PBS, the cells were incubated with FITCconjugated secondary antibodies (1:100) and Cyc3-conjugated secondary antibodies (1:1000) diluted with PBS at 37 °C for 2 h. After mounted by cover glass, images were acquired by confocal laser scanning microscope (CLSM). 
Migration Assays
For scratch-wounding cell migration assay, the PASMCs cultured in 6-well plates were wounded by pipette tips, given rise to one acellular 1-mm-wide lane per well, and the ablated cells were washed out with PBS. After that, cells were treated with vehicle or chemicals of interest in 5% FBS DMEM. Migration was calculated based on the samewounded areas at time zero and 24 h.
Flow cytometry
Annexin V-PE, 7-AAD kit was used to measure the percentage of apoptosis in accordance with the 5 ) were collected and resuspended in 100ml of binding buffer containing annexin V-PE and 7-AAD, then incubated for 15min in the dark at room temperature, and the percentage of apoptotic cells was immediately assessed using a TUNEL with 4% paraformaldehyde phosphate buffer saline, rinsed with PBS, and then permeabilized by 0.1% TritonX-100 for 2 min on ice followed by TUNEL for 1h at 37°C. The FITC-labeled TUNEL-positive cells were Nuclear morphology determination Quantitative nuclear chromatin morphology was employed for the apoptosis counting. PASMCs were 488 nm excitation and 405 nm emission. Cells with nuclear crenation, nuclear condensation and nuclear
Measurement of caspase activity
Caspase activities were detected by cleavages of Ac-DEVD-pNA (acetyl-Asp-Glu-Val-Aspp-nitroanilide), a caspase-3 substrate, and AC-LEHD-pNA (acetyl-Leu-Glu-His-Asp p-nitroanilide), a caspase-9 substrate, were normalized to the total protein and then expressed as fold changes of caspase-3 and caspase-9 activities compared with control cells (cultured in DMEM with10% FBS). 
Measurement of 15-HETE levels

estern lot Analysis
The protein samples were extracted from PASMCs cells with the procedures essentially the same as described in details previously [7] . Protein samples (20~50 μg) were fractionated by SDS-PAGE (7.5-10% polyacrylamide gels). The primary antibodies against p-ERK ( 
Statistics
The composite data are expressed as means ± SEM. Statistical analysis was performed with one-<0.05 were considered statistically The morphology analysis of pulmonary arterial was examined with H&E stain. The results showed that the medial wall thickness was higher in human PH patients compared with that of normal human(**P<0.01; n=5). B: The RVSP data showed that the RVSP in patient with PH was increased(***P <0.001 ; n=5). C: Summarized data showed that the PVR was enhanced in patient with PH (***P <0.001; n=5). D: The protein expression of 15-LO-2 in human pulmonary vessels (***P<0.001; n=5). E: The endogenous level of 15-HETE measured by 15-HETE EIA kit in human(***P <0.001 ; n=5). F: The expression of MAPK was detected pulmonary vessels in human PH at protein level (***P<0.001vs normal human n=5). Bars are presented as mean ± SEM."Ctl" means control; "PH" means pulmonary hypertension. (Fig. 1D) . Furthermore, ELISA showed that the level of endogenous 15-HETE was drastically elevated in pulmonary arteries from human PH (Fig. 1E) . On the other hand, MAPKs expression was detected the protein levels of phosphorylated extracellular signal-regulated kinase (p-ERK) and phosphorylated p38 mitogen-activated protein kinases (p-p38MAPK), but not phosphorylated c-Jun N-terminal kinase (p-JNK), were enhanced in pulmonary arteries of human PH patients (Fig. 1F) . These data suggest that 15-LO-2/15-HETE and MAPKs somehow implicated in the pulmonary arterials remodeling during development of PH.
15-L inhi ition prevented hypoxic PH and the expression of MAPKs signaling in hypoxic PH in rats
Hypoxic induced PH rat model was used to test whether 15-LO-2/15-HETE and MAPKs involved in pulmonary arterials remodeling. Similar remodeling of medium-size pulmonary P<0.01; n=5). B: Representative tracings of RV pressures in normoxic, chronically hypoxic rat and chronically hypoxic rat treated with NDGA. C: Bar graphs (means ± SEM) showed the result of RVSP in hypoxic model (**P<0.01; n=5). D: Bar graphs (means ± SEM) showed RV/LV+S weight ratio in rat exposed to normoxia or hypoxia in the absence or presence of NDGA (**P<0.01; n=5). E:The expression of 15-LO-2 in vessels of rats from hypoxia model (***p<0.001; n=5). F: The endogenous level of 15-HETE measured by 15-HETE EIA kit in rat (**P; 0.01; n=5). G: The protein expression of MAPK in vessels of hypoxic rat model (**P<0.01; n=5). Bars are presented as mean ± SEM. "Ctl" means control;"HYP"means hypoxia; "HYP+N"means "hypoxia+ND-GA". increased compared with normoxic rats. The increasing was inhibited by administration of NDGA, a lipoxygenase inhibitor (Fig. 2A) . RV pressure and heart weights were used elevated RVSP and RV/LV+S in rats, while the elevation was reversed by NDGA (Fig. 2B, C,  D) . We measured the expression of 15-LO-2 in tissue levels. Hypoxia augmented the protein expressions of 15-LO-2, whereas NDGA reversed this effect (Fig. 2E) . In addition, endogenous the 15-HETE level in pulmonary arteries was increased in hypoxic rats, the increasing was reversed by administration of NDGA (Fig. 2F) .Consistent with the observation from human PH patients, hypoxia augmented the protein expressions of p-ERK and p-p38MAPK, but not p-JNK, in rat pulmonary arteries, and the increasing expression of p-ERK and p-p38MAPK were decreased by administration of NDGA (Fig. 2G) . These results indicated that 15-LO- Both effects were greatly reversed by U0126 or by SB203580 (Fig. 5A) . Similar effect were OPN induced by hypoxia was also abolished by ERK or P38MAPK inhibitors in rats PASMCs (Fig. 5B & 5C) . U0126 or SB203580. In addition, exogenous 15-HETE did not reverse the effects of MAPK inhibitors on differentiation and migration of PASMCs (Fig. 5D) . To elucidate the effect of ERK and p38MAPK signaling pathways on rat PASMCs proliferation, which is a key component of PVR, we suppressed ERK and p38MAPK by U0126 and SB203580 respectively in cultured rat PASMCs under hypoxia condition, then measured the cell viability, Brdu incorporation and the expression of proliferating cell nuclear antigen (PCNA). Hypoxia regulation of PCNA expression induced by hypoxia was also abrogated by the ERK and p38MAPK inhibitors (Fig. 5G) . Consistent with the observation in migration experiments, exogenous 15-HETE did not reverse the effects of MAPK inhibitors on proliferation of rat PASMCs. These data indicated that the effect of 15-LO-2/15-HETE on proliferation of PASMCs is likely mediated by ERK and p38MAPK signaling pathways.
MAPKs participated in the Cell-cycle transition from G0/G1 Phase to S Phase plus G2/M phase in rat PASMCs which was Forward Cataly ed y 15-HETE
To elucidate whether the ERK and P38MAPK signaling pathways participate in15-HETE-mediated cell cycle activity, the number of cells in each phase of cell cycle was "Ctl"means control; "U" means "U0126"; "SB" means "SB203580"; "15" means 15-HETE. /G 1 -phase cells was increased when treated with U0126 or SB203580 respectively (Fig. 6A) . Since cyclin-A, cyclin-D1 and cyclin-E play important roles in both the S and G 2 /M phases [35] , we analyzed the posttranslational levels of cyclin-A, cyclin-D1 and cyclin-E in rat PASMCs. A treating U0126 or SB203580 respectively (Fig. 6B, 6C, 6D) . However, exogenous 15-HETE could not reverse the effects of MAPK inhibitors on regulate cell cycle of rat PASMCs. These data showed that the 15-LO-2/15-HETE/MAPK was involved in the cell cycle regulation rat PASMCs.
15-HETE protected rat PASMCs from apoptosis through MAPK
As both the increase of proliferation and the decrease of apoptosis in rat PASMCs can lead to the pulmonary arterial medial hypertrophy, we applied serum deprivation (SD) as an apoptotic approach to study whether MAPKs participated in the anti-apoptotic effects on rats PASMCs under hypoxic condition. As shown in Fig. 8, SD produced a large population of Annexin V-positive cells (from 17.9 ±0.4% to 45.45 ± 0.5%), and the percentage of apoptotic protection effects of 15-HETE on cell apoptosis were attenuated in the presence of U0126 or SB203580 (24.9±0.7% and 19.9±0.6% respectively, Fig. 7) . Besides, SD increased the TUNELpositive cells in PASMCs, which was also inhibited by 15-HETE in an MAPK dependent manner that the 15-HETE inhibited SD-induced apoptosis in PASMCs, and the inhibitory effect of 15-HETE was attenuated by ERK inhibitors or p-38MAPK inhibitors. In addition, the increase of caspase-3 and capase-9 activities was observed in serum deprivation PASMCs, and 15-HETE restrained the caspase-3 and caspase-9 activation, the inhibitory effect of 15-HETE ERK and p38MAPK pathways were necessary for the inhibition effect of 15-HETE on SDinduced apoptosis.
Discussion
We have been proved that hypoxia induced pulmonary vascular remodeling is mediated by 29] . However, the molecular mechanisms underlying 15-HETE mediated pulmonary remodeling still not fully understand. Recent studies suggested that MAPKs contributed to the hypoxia-induced PH development and the associated pulmonary vascular remodeling. Here we demonstrated that the expression of15-LO-2, p-ERK and p-p38MAPK were enhanced in the pulmonary vasculature of PH patients. By using hypoxia-induced PH rat models and in vitro culture rat PASMCs, we further elucidated that the 15-LO-2/15-HETEMAPKs pathway underlying hypoxia-induced pulmonary vascular remodeling through regulation of PASMC trans-differentiation, migration, proliferation/apoptosis and cell cycle progress.
In our study, we found that the expression of p-ERK and p-p38MAPK were increased in pulmonary vascular of PAH patients. These results indicated that ERK and p38MAPK signaling pathways were involved in the pathological process of PAH. And the effects of MAPKs PAH. The U0126 or SB203580 could ameliorate hypoxia-elevated RVSP and Right ventricular hypertrophy. Evidently, the inhibition of ERK and p38MAPK by administrating a chemical inhibitor prevented and reversed the experimental PAH. These results are consistent with the previous study, which showing that activation of ERK and p38MAPK appears to be associated with hypoxia-induced pulmonary vascular remodeling [9] .
In our previous studies, we have found that 15-HETE mediates pulmonary adventitia we found that p-ERK and p-p38MAPK expression was reversed in pulmonary vasculatures by NDGA (a lipoxygenase inhibitor) in hypoxia-induced PH rat (Fig. 2G) . Moreover, hypoxia increase the phosphorylation of ERK and p38MAPK, the effect is inhibiting by siRNA targeted 15-LO-2 in cultured rat PASMCs (Fig. 3D-3E ). These results indicate that 15-LO-2/15HETE was essential for hypoxia-activated ERK and p38MAPK in PASMCs. Previous studies have shown that chronic hypoxia induced phenotypical switches of the PASMCs from the contractile and well differentiated phenotype to the synthetic and dedifferentiated phenotype [36] . Such alterations caused the vascular SMCs to regain their proliferative and migratory capacities and also enable their capability to secrete matrix proteins [36] . These pathological processes appear to be related to the PAH. In this study, expression of OPN. And this phenotype switching is largely eliminating by ERK or p38MAPK inhibitor (U0126 or SB203580). Meanwhile, the results also show that p-ERK and p-p38MAPK promoted the migration of PASMCs.
Increased phosphorylation of ERK and p38MAPK mediates hypoxia-increased the proportion of cells in the S and G 2 /M phases in PASMCs. The process may be through direct or indirect stimulation of cyclin A, cyclin D1 and cyclin E expression, all of which are known to regulate the cell cycle progression and play important roles in the both S and G 2 /M phases. The information thus provided direct evidence that p-ERK and p-p38MAPK activate cell cycle arrest in cancer cells [37] . Secondly, p38MAPK signaling also modulate mammalian cell cycle by antagonizing the effects of ERK mediated Cyclin D expression and thus regulating the G1/ S cell cycle arrest [37] .
The pathologic processes of pulmonary vascular remodeling were correlated with activation of p38MAPK or ERK, promoted PASMCs phenotype changed caused the PASMCs migration and proliferation. In addition, the p38MAPK and ERK regulated the cell cycle progression, which increased medial thickening and leads to vascular remodeling. Besides, time that the MAPK signaling pathways participate in the pathological process of hypoxiaPrevious reports have showed that 5-hydroxytryptamine (5-HT) stimulated PASMCs proliferation and migration by activating JNK [24] . However, our results identify that there were no changed in the expression of p-JNK in the pulmonary arterial from both PAH patients and rat PAH models. We purposed that phosphorylation of JNK might be correlated with pulmonary vessels response to prophase of hypoxia, but not the later stage. This was support after 7 day of hypoxia [9] .
A limitation in our study is the using of NDGA as 15-LO inhibitor. NDGA is a nonselective lipoxygenase inhibitor which blocks cysteinyl-leuotriene synthesis. The IC50 values are 3.0-5.0μM for human platelet 12-lipoxygenase and 0.91μM for rabbit reticulocyte 15-lipocygenase; 0.2 μM for 5-lipoxygenase [38, 39] . The dose tested in this study was 1μM for rat PASMCs 15-lipocygenase, which limited the off-targets inhibition of NDGA on other
